AMINOSYN 8.5% W/ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic
NDAINJECTIONINJECTABLE
Approved
Dec 1975
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN 8.5% W/ELECTROLYTES is a parenteral nutrition solution containing amino acids, electrolytes, and minerals administered intravenously. It is used to provide essential amino acids and electrolyte replacement in patients requiring nutritional support when oral intake is not feasible. The formulation delivers balanced protein nutrition with critical electrolytes (sodium, potassium, magnesium, phosphate) for metabolic homeostasis.
LOE Approaching
As a mature, hospital-based nutritional product nearing loss of exclusivity, teams are typically small and focused on defending market position against generic/competitive alternatives rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN offers stability and deep healthcare system relationships, but limited growth runway given LOE status and minimal linked job opportunities (0 roles). Careers here emphasize operational excellence, cost management, and defending established market position rather than innovation or expansion.
Hospital Account ManagerClinical Nutrition Specialist
Worked on AMINOSYN 8.5% W/ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.